Scientific article

Spécificités de l’infection à SARS-CoV-2 chez les patients âgés

Other title[Specificities of SARS-CoV-2 infection in elderly patients]
Published inRevue médicale suisse, vol. 18, no. 777, p. 702-706
Publication date2022-04-13

COVID-19 has strongly impacted the elderly population with a particularly high mortality rate due to several reasons: sometimes difficult and delayed diagnosis, multimorbidity, immunosenescence, frailty, which seems to be a better prognostic marker than age. Treatment includes both therapies specifically directed against SARS CoV-2 (monoclonal antibodies, systemic corticosteroids, tocilizumab, remdesivir) and symptomatic and palliative treatments. Vaccination, especially the booster, is essential to reduce the risk of infection and severe forms. The emergence of variants is a challenge because of their impact on vaccine and treatment efficacy. Specific studies in the elderly are needed to improve their management.

  • Aged
  • COVID-19
  • COVID-19 Vaccines
  • Frailty
  • Humans
  • SARS-CoV-2
  • Vaccination
Citation (ISO format)
PARENT, Thibault et al. Spécificités de l’infection à SARS-CoV-2 chez les patients âgés. In: Revue médicale suisse, 2022, vol. 18, n° 777, p. 702–706. doi: 10.53738/REVMED.2022.18.777.702
Main files (1)
Article (Published version)
accessLevelRestrictedaccessLevelPublic 10/14/2023
ISSN of the journal1660-9379

Technical informations

Creation02/07/2023 10:05:39 AM
First validation05/22/2023 12:24:13 PM
Update time05/22/2023 12:24:13 PM
Status update05/22/2023 12:24:13 PM
Last indexation08/31/2023 11:15:33 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack